C3 Biotechnologies Limited

Active09620994 Private limited company
Incorporated
3 June 2015 (11 years)
Previously known as
C3 Bio-Technologies Limited (until 14 September 2020)
This list may be incomplete. See all names on Companies House
Industry
Research and experimental development on biotechnology (72110)
Owned by
Nigel Scrutton
Accounts type
Small
Region
North West
Address
20 Mannin Way
Lancaster Business Park
Caton Road
Lancaster
LA1 3SW

Filing status

Accounts due
30 June 2027
Last accounts
30 September 2025
Conf. stmt due
17 June 2027
Last conf. stmt
3 June 2026

Officers 2 active

Officer details are public data from the Companies House register.

Officer history (6 former)
8 October 2026
Appointed Dockney, Jonathan as Director
2 July 2026
Appointed Smith, Michael Hyde as Director
2 July 2026
Resigned Scrutton, Nigel, Professor as Director
25 June 2026
Resigned Dennison, Phillip as Secretary
24 June 2026
Resigned Smith, Michael Hyde as Director
14 September 2022
Resigned Cw And R Limited as Corporate Secretary
14 September 2022
Appointed Dennison, Phillip as Secretary
23 March 2021
Appointed Cw And R Limited as Corporate Secretary
23 March 2021
Resigned Armer, Tracy as Secretary
12 August 2015
Appointed Armer, Tracy as Secretary
12 August 2015
Appointed Scrutton, Nigel, Professor as Director
3 June 2015
Appointed Kahan, Barbara as Director
3 June 2015
Resigned Kahan, Barbara as Director
3 June 2015
Appointed Smith, Michael Hyde as Director

Ownership 2 active

People and entities with significant control, from the Companies House PSC register

Nigel Scrutton
Individual · Notified 4 June 2016
Owns 25–50% of shares
Holds 25–50% of voting rights
Right to appoint and remove directors (as a firm)
British
Born April 1964 (62)
Individual · Notified 25 April 2016
Has significant influence or control
British
Born April 1958 (68)

Holdings 5

Companies where C3 Biotechnologies Limited is registered as a person with significant control

Active
Active
Status not confirmed
Status not confirmed
Active
Former controllers (3)
1 July 2026
Ceased Michael Hyde Smith — Owns 75–100% of shares
1 July 2026
Ceased Michael Hyde Smith — Has significant influence or control
25 April 2016
Ceased Nigel Shaun Scrutton — Has significant influence or control

Financials

Balance sheet as at 30 September 2025 · small accounts

Net Assets
£405,818
Cash
£97,087
Employees
11
Debt Ratio
31%
Current Ratio
0.8x

Trend

Net Assets
(£500k) £0 £500k £1.0M 2019 2020 2022 2023 2024 2025 (£98,806) (£90,023) £631,778 £589,815 £441,748 £405,818
Balance sheet detail
202520242023202220202019
Fixed Assets£442,901£473,735£419,071£354,105£153,474£122,321
Current Assets£148,135£247,379£432,523£705,452£37,973£45,033
Debtors£51,048£87,323£156,558£112,721£30,563£44,021
Cash£97,087£160,056£275,965£592,731£7,410£1,012
Creditors (< 1 year)£185,218£255,876£184,417£276,507£129,399£266,160
Creditors (> 1 year)£0£8,006£58,769£132,516£152,071
Net Current Assets(£37,083)(£8,497)£248,106£428,945(£91,426)(£221,127)
Net Assets£405,818£441,748£589,815£631,778(£90,023)(£98,806)
Shareholder Funds£405,818£441,748£589,815£631,778(£90,023)(£98,806)

Filings

Filing history not loaded yet. See it on Companies House

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?